Clinical trials for Tuberculosis
60 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University · PI: Akshay Gupte, PhD MBBS MSPH
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati · PI: Sanjay Jain, MD
- ENROLLING BY INVITATIONN/ANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco · PI: Adithya Cattamanchi, MD
- RECRUITINGN/ANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet · PI: Lina Davies Forsman, MD, PhD
- RECRUITINGPhase 3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University · PI: Ethel M Weld, MD
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine
- RECRUITINGPhase 3NCT07152639Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and AboveChengdu CoenBiotech Co., Ltd
- RECRUITINGPhase 1NCT06714513ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74Quratis Inc. · PI: Jinhee Lee, DVM, PhD
- RECRUITINGN/ANCT06909799A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung DiseaseThe Aurum Institute NPC · PI: Robert Wallis - Professor
- RECRUITINGNCT06439810Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNAChinese University of Hong Kong · PI: Ka Pang Chan, MBChB
- RECRUITINGPhase 2NCT06997367Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)Bharat Biotech International Limited · PI: Dr.V.Krishna Mohan, PhD
- ACTIVE NOT RECRUITINGNCT07357844Pediatric Optimal Tuberculosis Treatment Evaluation and ReassessmentHospices Civils de Lyon
- ACTIVE NOT RECRUITINGN/ANCT06670755ID93/GLA-SE Vaccination + BCG ChallengeUniversity of Oxford · PI: Helen McShane, Professor
- RECRUITINGPhase 2NCT06477185Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using DoxycyclineMakerere University
- ACTIVE NOT RECRUITINGNCT06737029Alternative Diagnoses in Patients About to Start Empiric Tuberculosis TreatmentStichting Longartsen voor Afrika
- RECRUITINGNCT06526689Lung Innate Immunity and Microbiome After Tuberculosis ExposureUniversity of Oxford · PI: Helen McShane, PhD
- RECRUITINGNCT06700876Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KTMahidol University · PI: Punnee Pitisuttithum, Prof. E.
- ENROLLING BY INVITATIONNCT06744179Post TB Sequelae StudyInternational Centre for Diarrhoeal Disease Research, Bangladesh
- ACTIVE NOT RECRUITINGNCT06539455Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis DrugsStefania Cheli
- RECRUITINGN/ANCT07117370Assessing the Feasibility of Coach Mpilo for Men With TB and HIVArizona State University
- ACTIVE NOT RECRUITINGPhase 1NCT06050356First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10bStatens Serum Institut · PI: Gavin Churchyard, PhD
- RECRUITINGPhase 4NCT06484530Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced HepatitisMahidol University · PI: Supot Nimanong
- RECRUITINGNCT06403800Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern TanzaniaNational Heart and Lung Institute
- RECRUITINGPhase 3NCT06057519Pragmatic Optimized Rifampicin TrialRadboud University Medical Center · PI: Martin Boeree
- RECRUITINGNCT06221488Testing Health Workers At Risk to Advance Our Understanding of TB InfectionBeth Israel Deaconess Medical Center · PI: Ruvandhi Nathavitharana, MBBS MPH
- RECRUITINGN/ANCT06159023Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TBPusan National University Hospital · PI: Jeongha Mok
- ACTIVE NOT RECRUITINGPhase 2NCT05556746Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TBBrigham and Women's Hospital · PI: Serena Koenig, MD, MPH
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05766267Short-course Regimens for the Treatment of Pulmonary TuberculosisCenters for Disease Control and Prevention · PI: Kelly Dooley, MD
- RECRUITINGPhase 3NCT06022146TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool ContactsHuashan Hospital
- RECRUITINGNCT06033807Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis PatientsHuashan Hospital · PI: Wenhong Zhang, PhD
- RECRUITINGPhase 3NCT05899179Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and AboveAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · PI: Shuihua Lu, bachelor
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05547464Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated VolunteersBioNTech SE · PI: BioNTech Responsible Person
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05686356A Pan-TB Regimen Targeting Host and MicrobeThe Aurum Institute NPC · PI: Professor Robert Wallis, MD
- RECRUITINGPhase 3NCT05473520Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary TuberculosisNational University Hospital, Singapore · PI: Catherine Ong, MRCP PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05122767Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)The Aurum Institute NPC · PI: Nicole Salazar-Austin
- ACTIVE NOT RECRUITINGPhase 4NCT05680415Clinical Trial of MicaAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · PI: Yi Mo, Master
- RECRUITINGPHASE2, PHASE3NCT05401071Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)Huashan Hospital · PI: Wenhong Zhang, PhD.
- RECRUITINGNCT06522347Mycobacteria Registry Study: Prospective Observational Study in AustriaLudwig Boltzmann Institute for Lung Health
- RECRUITINGPhase 4NCT05381194BPaL(M) Regimen for the Treatment of MDR/RR-TBAsan Medical Center
- RECRUITINGPhase 3NCT04975178Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan AfricaBiofabri, S.L · PI: Mark Hatherill
- ACTIVE NOT RECRUITINGPhase 4NCT05411744One-month Latent Tuberculosis Treatment for Renal Transplant CandidatesRutgers, The State University of New Jersey · PI: Pinki Bhatt, MD
- RECRUITINGN/ANCT05656287My Mobile Wallet: An Intervention for Tuberculosis Medication Adherence in Rural UgandaMbarara University of Science and Technology · PI: Angella Musiimenta, PhD
- ACTIVE NOT RECRUITINGN/ANCT05220163Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19University of Cape Town · PI: Keertan Dheda, PhD
- ACTIVE NOT RECRUITINGNCT05840809Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant PairsUniversity of Liverpool
- RECRUITINGPhase 4NCT05588492The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot StudyNational Taiwan University Hospital · PI: Chin-Chung Shu
- RECRUITINGNCT06764576Patients With Tuberculosis, Mycobacteriosis or Latent TuberculosisIRCCS Azienda Ospedaliero-Universitaria di Bologna · PI: Paola Dal Monte, MD
- RECRUITINGNCT05073926Rifampicin Resistance in S. Aureus During and After Treatment for Latent TuberculosisRegion Skane
- ACTIVE NOT RECRUITINGNCT04926922PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in LiberiaNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Stephen A Migueles, M.D.
- ACTIVE NOT RECRUITINGPhase 1NCT04538911Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis PatientsAnhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · PI: Shuihua Lu, Bachelor
- RECRUITINGNCT04642755Comorbidities and Coinfections in Latent TBTuberculosis Research Centre, India · PI: Subash Babu, MBBS, PhD
- RECRUITINGN/ANCT04923958Rapid Research in Diagnostics Development for TB NetworkUniversity of California, San Francisco · PI: Adithya Cattamanchi, MD
- ACTIVE NOT RECRUITINGN/ANCT04844502Cardiopulmonary Function and Quality of Life in Pulmonary TuberculosisUniversidade Federal do Rio de Janeiro
- ACTIVE NOT RECRUITINGNCT05044910The Impact of Malnutrition on Immune Responses to TuberculosisTuberculosis Research Centre, India · PI: Aishwarya Venkataraman, MRCPCH
- RECRUITINGPHASE2, PHASE3NCT04147286Atorvastatin to Reduce Inflammation After Tuberculosis Treatment CompletionUniversity of Cape Town · PI: Friedrich Thienemann, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04856644Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TBKaohsiung Veterans General Hospital. · PI: Susan Shin-Jung Lee, M.D., Ph.D.
- RECRUITINGNCT03691883Design of an Integrative Algorithm for Staging TuberculosisFundació Institut Germans Trias i Pujol · PI: Cris Vilaplana, MD, PhD
- ACTIVE NOT RECRUITINGNCT06838780Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TAChinese University of Hong Kong
- ACTIVE NOT RECRUITINGN/ANCT03042754Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care HospitalsThe HIV Netherlands Australia Thailand Research Collaboration · PI: Gompol Suwanpimolkul, MD